The effects of ketamine on symptoms of depression and anxiety in real-world care settings: A retrospective controlled analysis.
Journal of Affective Disorders May 1, 2023 Tuuli M. Hietamies, L. Mcinnes, A. Klise et al.
INTRODUCTION Ketamine intravenous therapy (KIT) appears effective for treating depression in controlled trials testing a short series of infusions. A rapidly proliferating number of clinics offer KIT for depression and anxiety, using protocols without a strong evidence basis. Controlled comparison of mood and anxiety from real-world KIT clinics, and the stability of outcomes, is lacking....